RESMED INC - Common Stock (RMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RMD on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
146M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91.4M
Holdings value
$25B
% of all portfolios
0.018%
Grand Portfolio weight change
0%
Number of holders
930
Number of buys
447
Number of sells
-393
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13.66% $5.48B 20M The Vanguard Group 30 Sep 2025

Institutional Holders of RESMED INC - Common Stock (RMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91.4M $25B -$152M $273.73 930
2025 Q2 92.3M $23.8B -$235M $258.00 911
2025 Q1 93.3M $20.9B +$659M $223.85 872
2024 Q4 90.1M $20.6B +$523M $228.69 863
2024 Q3 86.8M $21.2B +$357M $244.12 792
2024 Q2 85.4M $16.3B +$455M $191.42 768
2024 Q1 82.9M $16.4B +$513M $198.03 710
2023 Q4 80.4M $13.8B -$1.27B $172.02 680
2023 Q3 87.7M $13B -$1.62B $147.87 648
2023 Q2 95.1M $20.8B -$112M $218.50 724
2023 Q1 95.3M $20.9B +$76.8M $218.99 665
2022 Q4 95.6M $19.9B -$214M $208.13 717
2022 Q3 96.5M $21.1B -$40.8M $218.30 650
2022 Q2 96.4M $20.2B -$217M $209.63 661
2022 Q1 97.3M $23.6B +$638M $242.51 658
2021 Q4 94.5M $24.6B -$551M $260.48 703
2021 Q3 96.3M $25.4B -$115M $263.55 673
2021 Q2 96.7M $23.8B -$549M $246.52 650
2021 Q1 99M $19.2B -$384M $194.02 649
2020 Q4 101M $21.5B +$125M $212.56 652
2020 Q3 101M $17.2B -$286M $171.43 612
2020 Q2 102M $19.6B +$701M $192.00 567
2020 Q1 98.4M $14.5B +$119M $147.29 574
2019 Q4 97.6M $15.1B +$143M $154.97 551
2019 Q3 96.6M $13.1B +$38.4M $135.11 514
2019 Q2 96.4M $11.8B +$23.5M $122.03 475
2019 Q1 97.6M $10.1B -$14.2M $103.97 468
2018 Q4 97.6M $11.1B +$398M $113.87 489
2018 Q3 94.1M $10.8B +$178M $115.34 486
2018 Q2 92.5M $9.58B +$226M $103.58 455
2018 Q1 90.2M $8.88B +$144M $98.47 435
2017 Q4 89.3M $7.56B +$29.2M $84.69 410
2017 Q3 88.9M $6.84B +$166M $76.96 359
2017 Q2 86.8M $6.76B +$42.2M $77.87 335
2017 Q1 86.8M $6.25B +$814M $71.97 368
2016 Q4 88.1M $5.46B -$132M $62.05 356
2016 Q3 90M $5.83B +$198M $64.79 368
2016 Q2 87M $5.5B +$227M $63.23 355
2016 Q1 83.5M $4.83B +$24.5M $57.82 365
2015 Q4 82.8M $4.45B +$287M $53.69 346
2015 Q3 77.3M $3.93B +$122M $50.96 310
2015 Q2 74.6M $4.2B +$13M $56.37 310
2015 Q1 73.5M $5.27B -$59.4M $71.78 323
2014 Q4 74.7M $4.19B +$85.6M $56.06 302
2014 Q3 72.8M $3.58B -$145M $49.27 297
2014 Q2 75.6M $3.83B -$208M $50.63 308
2014 Q1 80.1M $3.58B +$1.48M $44.69 314